113 related articles for article (PubMed ID: 2987309)
1. Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung.
Mabry M; Speak JA; Griffin JD; Stahel RA; Bernal SD
J Clin Invest; 1985 May; 75(5):1690-5. PubMed ID: 2987309
[TBL] [Abstract][Full Text] [Related]
2. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
Stahel RA; Mabry M; Sabbath K; Speak JA; Bernal SD
Int J Cancer; 1985 May; 35(5):587-92. PubMed ID: 2987136
[TBL] [Abstract][Full Text] [Related]
3. Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung.
Bernal SD; Mabry M; Stahel RA; Griffin JD; Speak JA
Cancer Res; 1985 Mar; 45(3):1026-32. PubMed ID: 2982482
[TBL] [Abstract][Full Text] [Related]
4. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody.
Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F
Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239
[TBL] [Abstract][Full Text] [Related]
5. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic murine monoclonal antibody LAM8 with specificity for human small cell carcinoma of the lung.
Stahel RA; O'Hara CJ; Mabry M; Waibel R; Sabbath K; Speak JA; Bernal SD
Cancer Res; 1986 Apr; 46(4 Pt 2):2077-84. PubMed ID: 3004719
[TBL] [Abstract][Full Text] [Related]
7. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
8. Expression of antigens associated with small cell carcinoma of the lung on hematopoietic progenitor cells.
Ball ED; Keefe KA; Colby E
Cancer Res; 1987 Dec; 47(24 Pt 1):6556-9. PubMed ID: 2824035
[TBL] [Abstract][Full Text] [Related]
9. Membrane antigen in small cell carcinoma of the lung defined by monoclonal antibody SM1.
Bernal SD; Speak JA
Cancer Res; 1984 Jan; 44(1):265-70. PubMed ID: 6317170
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic applications of monoclonal antibodies to small cell carcinoma of the lung.
Okabe T; Takaku F
Jpn J Clin Oncol; 1986 Sep; 16(3):243-52. PubMed ID: 3022033
[TBL] [Abstract][Full Text] [Related]
11. Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small-cell carcinoma and squamous-cell carcinomas.
Stahel RA; Speak JA; Bernal SD
Int J Cancer; 1985 Jan; 35(1):11-7. PubMed ID: 2578439
[TBL] [Abstract][Full Text] [Related]
12. Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.
Saarinen UM; Coccia PF; Gerson SL; Pelley R; Cheung NK
Cancer Res; 1985 Nov; 45(11 Pt 2):5969-75. PubMed ID: 2414004
[TBL] [Abstract][Full Text] [Related]
13. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
Elias AD; Pap SA; Bernal SD
Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
[TBL] [Abstract][Full Text] [Related]
14. Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow.
Duerst RE; Rose D; Frantz CN
Exp Hematol; 1991 Oct; 19(9):863-7. PubMed ID: 1893961
[TBL] [Abstract][Full Text] [Related]
15. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32).
Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW
J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020
[TBL] [Abstract][Full Text] [Related]
16. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J
Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
[TBL] [Abstract][Full Text] [Related]
17. Elimination of malignant clonogenic cells from human bone marrow using multiple myeloid cell-specific monoclonal antibodies and complement.
Hu ZB; Yu ZF; Qiao CN; Ma WL
Chin Med J (Engl); 1991 Aug; 104(8):664-8. PubMed ID: 1914634
[TBL] [Abstract][Full Text] [Related]
18. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
[TBL] [Abstract][Full Text] [Related]
19. [Application of monoclonal antibodies to diagnosis and treatment of small cell lung cancers].
Fujisawa M; Okabe T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):984-9. PubMed ID: 2839119
[TBL] [Abstract][Full Text] [Related]
20. Elimination of clonogenic stem cells from human multiple myeloma cell lines by a plasma cell-reactive monoclonal antibody and complement.
Tong AW; Lee JC; Fay JW; Stone MJ
Blood; 1987 Nov; 70(5):1482-9. PubMed ID: 3663943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]